ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS Article

Bell, Erica H, Zhang, Peixin, Shaw, Edward G et al. (2017). ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS . NEURO-ONCOLOGY, 19(suppl_6), vi8-vi8. 10.1093/neuonc/nox168.028

cited authors

  • Bell, Erica H; Zhang, Peixin; Shaw, Edward G; Buckner, Jan C; Barger, Geoffrey R; Coons, Stephen W; Bullard, Dennis E; Mehta, Minesh P; Gilbert, Mark R; Brown, Paul D; Stelzer, Keith J; Fleming, Jessica; McElroy, Joseph P; Timmers, Cynthia D; Becker, Aline Paixao; Salavaggione, Andrea L; Liu, Ziyan; Aldape, Ken; Brachman, David G; Gertler, Stanley Z; Murtha, Albert D; Schultz, Christopher J; Johnson, David; Shu, Hui-Kuo; Chakravarti, Arnab

authors

publication date

  • November 6, 2017

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 4 Detection, screening and diagnosis
  • 4.2 Evaluation of markers and technologies
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Genetics

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vi8

end page

  • vi8

volume

  • 19

issue

  • suppl_6